← Leaderboards
Stanley Adoro
Case Western Reserve University
$1,747,993
Attributed
$1,747,993
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $465.9K · FY2017–21$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,747,993 · 2
By mechanism
R01$1,362,843 · 1
K22$385,150 · 1
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Jonathan Karn$45,795,060
- Ravi V Bellamkonda$14,562,299
- Analisa Virginia Difeo$3,927,736
- Christina Farr Zuend$965,282
- Douglas Brubaker$844,532
Others in their field
Other Emerging Leaders on “Pathway Interactions”
- April Brinkoetter · Hungry Heart Media, Inc.$59,802,265
- Kevin Urdahl · Seattle Children'S Hospital$47,227,116
- Urs Ochsner · Crestone, Inc.$38,569,476
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
- Nader Fotouhi · Global Alliance For Tb Drug Development$28,468,137
- Jeffrey Glenn · Stanford University$26,017,226
Research focus
Pathway InteractionsHomeostasisGenesMutationSignal TransductionCellsCell PhysiologyEnzymesInnovationMediatingProgramsProteinsPhosphotransferasesLaboratoriesAblationBiochemicalCause Of DeathDefectBone MarrowAnimal ModelBcl2 GeneCentral ToleranceAnimal GeneticsBase
Grant awards (5)
Mechanisms of tunable posttranslational control of T-cell homeostasis and tolerance$445,980
R01 · FY2021 · AI · contact PI
Mechanisms of tunable posttranslational control of T-cell homeostasis and tolerance$450,932
R01 · FY2020 · AI · contact PI
Mechanisms of tunable posttranslational control of T-cell homeostasis and tolerance$465,931
R01 · FY2019 · AI · contact PI
Probing the role of the IRE1alpha-XBP1 pathway in normal and malignant hematopoiesis$192,575
K22 · FY2018 · CA · contact PI
Probing the role of the IRE1alpha-XBP1 pathway in normal and malignant hematopoiesis$192,575
K22 · FY2017 · CA · contact PI